Sample deliverable

What a BiomeLogic mechanistic report looks like

Three fictional samples — Standard, Deep Dive, and Lab Interpretation Review — showing the structure, depth, and uncertainty handling of the written deliverable. All cases and findings are synthetic.

Educational mechanistic analysis only. Not medical diagnosis, treatment, prescription, or a substitute for licensed clinical care. For urgent abnormalities, contact your clinician.

Sample · Standard Consultation

Post-prandial gut–immune reactivity with secondary energy-axis strain. Fluctuating tolerance to identical foods across days.

5–8 page equivalent

This is a fictional educational sample created to show the structure of a BiomeLogic mechanistic analysis. It is not based on a real client and is not medical advice.

Case snapshot
Pseudonym
Case A
Age range
Mid-30s
Presenting
Two years of post-meal bloating, intermittent flushing after fermented foods, and afternoon fatigue.
History
Prior workups across gastroenterology and allergy/immunology returned non-specific findings. Trials of low-FODMAP and antihistamines produced partial relief that did not persist.
Biological axes
  • Gut barrier & motilityStrained

    Variable transit, post-meal distention.

  • Mast-cell reactivityStrained

    Threshold-lowering pattern, not first-line activation.

  • Energy / mitochondrial reserveStrained

    Post-prandial fatigue out of proportion to meal size.

  • Autonomic regulationUncertain

    Orthostatic features not formally characterized.

  • Microbiome compositionUncertain

    No recent stool-based profile available.

Upstream / downstream hierarchy
  1. upstream
    Recurrent luminal disturbance

    Likely contributor to barrier perturbation; mechanism not fully characterized.

  2. midstream
    Barrier perturbation

    Sustained low-grade barrier strain proposed as a permissive factor.

  3. midstream
    Mast-cell threshold lowering

    Working hypothesis: barrier signal lowers degranulation threshold.

  4. downstream
    Post-prandial fatigue

    Energy axis appears reactive to upstream load, not the primary lesion.

Host Capacity Model interpretation

Within the Host Capacity Model, the picture reads as reduced post-prandial buffering capacity rather than a primary mast-cell or motility disorder. Capacity returns between exposures, which is consistent with strain rather than depletion.

Competing explanations
  • Primary motility disorder

    Bloating and post-meal symptoms driven by motility, with immune features secondary.

    For: Post-meal timing, distention pattern.
    Against: Reactivity tracks with food class, not meal volume alone.
  • Primary mast-cell activation pattern

    Threshold-lowered mast-cell activation as the leading mechanism.

    For: Flushing, partial antihistamine response.
    Against: Reactivity is intermittent and food-class linked, not constitutive.
  • Autonomic-led pattern

    Autonomic dysregulation drives gut symptoms downstream.

    For: Afternoon fatigue, possible orthostatic features.
    Against: Autonomic features have not been formally characterized.
Contradictions & uncertainty
  • Is the gut driving the immune pattern, or vice versa?
    Side A · Barrier perturbation lowers mast-cell threshold (gut → immune).
    Side B · Underlying mast-cell pattern destabilizes barrier (immune → gut).

    Current reading: Working interpretation favors gut → immune given partial response to dietary structure changes; remains a hypothesis.

Lab-cluster summary
  • Inflammation baseline
    hs-CRP · ferritin · ESR

    Markers within reference but trending toward upper-normal; consistent with low-grade strain, not active inflammation.

    Repeat during a symptomatic window for context.

  • Iron / energy
    ferritin · transferrin saturation · B12 · homocysteine

    Suggests adequate substrate but reduced flexibility; not a primary deficiency picture.

    Consider repeat fasting after standardized intake.

Mechanistic hypotheses
IDHypothesisTierSupportingGaps
H1Sustained barrier perturbation contributes to mast-cell threshold lowering.workingFood-class linked reactivity; Partial antihistamine response; Post-meal timingNo barrier-relevant panel; No symptom-window tryptase
H2Energy-axis strain is downstream amplification, not the primary lesion.exploratoryPost-meal fatigue exceeds meal loadNo standardized energy-axis assessment
Evidence-confidence table
ClaimTierNotes
Mast-cell threshold lowering is a working mechanism.workingSupported by symptom shape; not formally measured.
Motility disorder is the primary driver.exploratorySome features fit, others do not.
Autonomic axis is centrally involved.exploratoryInsufficient data to evaluate.
What this does not prove
  • It does not establish a diagnosis.
  • It does not establish causation between any single mechanism and symptom intensity.
  • It does not predict an individual response to any intervention.
Questions for the medical team
  • Would a structured 14-day food-symptom log change the picture?
  • Is there value in repeating tryptase / histamine during a symptomatic window?
  • Would a basic autonomic assessment clarify the orthostatic signal?
Suggested areas to discuss with a licensed clinician
  • Timing of any motility study relative to symptom windows.
  • Whether a stool-based profile is appropriate before further dietary structure changes.
  • Coordination between GI and allergy/immunology to avoid duplicated workups.
Educational next-test logic
  • Re-baselining inflammation markers during a symptomatic window often clarifies whether strain is constant or episodic.
  • A standardized barrier-relevant panel can help separate motility-led from immune-led readings.
Scope limitations
  • Educational mechanistic synthesis only — not diagnosis or care.
  • Hypotheses are interpretive and revisable as new data arrives.
  • Individual variation applies; this analysis does not predict outcomes.

If this is the kind of interpretive structure you are looking for, begin with Gate 1.

FAQ

Common questions about the sample

Is the sample based on a real client?
No. All cases, names, ages, labs, and findings are fictional. The sample illustrates the structure of a BiomeLogic mechanistic analysis, not any individual.
Is this medical advice?
No. BiomeLogic produces educational mechanistic analysis. It does not diagnose, treat, prescribe, or replace licensed clinical care.
Will my report look exactly like this?
The structure will be similar. Length, depth, and the specific axes covered depend on the complexity of your case and the data you submit.
Can I bring the report to my clinician?
Yes — the written summary is designed to be clinician-readable. Care-team discussion points are included for that purpose.
What if my case is less complex?
Less complex cases produce shorter, more focused reports. The hypothesis tiers and scope limitations are kept whether the case is large or small.
What if my labs are incomplete?
Reports explicitly note where data is insufficient. Educational next-test logic is included so you can discuss priorities with your clinician.
What is the difference between this and a functional medicine protocol?
BiomeLogic does not produce protocols. The deliverable is interpretive: a mechanistic synthesis you can use to think more clearly with your clinical team.
  • Educational systems-biology consulting · Not diagnosis
  • Not diagnosis or treatment
  • Works alongside your licensed care team
  • Written mechanistic summary
  • Fictional sample report available
  • No files required for Gate 1

For full provenance, see the Framework Audit, Counterargument Library, and Claim Ledger.